Page last updated: 2024-08-16

salmeterol xinafoate and Multiple Sclerosis

salmeterol xinafoate has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ascencio, M; Asche, CV; Raimondi, T; Rainville, EC; Ren, J; Valenzuela, RM1
Axelrod, S; Bielory, L1

Other Studies

2 other study(ies) available for salmeterol xinafoate and Multiple Sclerosis

ArticleYear
Association Between Exposure of Ipratropium and Salmeterol and Diagnosis of Multiple Sclerosis: A Matched Case-control Study.
    Clinical therapeutics, 2019, Volume: 41, Issue:8

    Topics: Adolescent; Adult; Aged; Bronchodilator Agents; Case-Control Studies; Female; Humans; Ipratropium; Male; Middle Aged; Multiple Sclerosis; Salmeterol Xinafoate; Young Adult

2019
Beta2-agonists and paresthesias in multiple sclerosis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007, Volume: 98, Issue:1

    Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase Inhibitors; Asthma; Bronchodilator Agents; Donepezil; Drug Therapy, Combination; Female; Fluticasone; Food Hypersensitivity; Humans; Indans; Interferons; Latex Hypersensitivity; Letrozole; Mandelic Acids; Middle Aged; Multiple Sclerosis; Nebulizers and Vaporizers; Nitriles; Nootropic Agents; Parasympatholytics; Paresthesia; Piperidines; Respiratory Function Tests; Salmeterol Xinafoate; Thyroxine; Triazoles

2007